PanTheryx
PanTheryx is the world's largest producer of bovine colostrum, commercializing proprietary colostrum ingredients and consumer brands (TruBiotics, DiaResQ, Life's First Naturals, Relesium) for digestive, immune, and GLP-1 side-effect support across human and animal health markets globally.
- Company typePrivate
- Founded2007
- HeadquartersBoulder, United States
- Headcount101–250
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What PanTheryx does
PanTheryx is a Boulder, Colorado-based nutrition and biotechnology company founded in 2007 that commercializes bovine colostrum-based products for human and animal health. The company operates as the world's largest producer of bovine colostrum, running vertically integrated operations spanning collection through processing at facilities in Phoenix, Arizona and Ripon, California. Its proprietary ColostrumOne ingredient, which delivers 160% more immune bioactives than competing colostrum products in an in vivo intestinal damage model (per a PLOS One study), underpins both its B2B ingredient supply business (ColostrumOne, La Belle, ColosIgG 24h) and its consumer brand portfolio (TruBiotics, Life's First Naturals, DiaResQ, Relesium, Goodgut, Preliva).
The company operates a hybrid revenue model across three streams. Its consumer branded products generate revenue through mass retail (Walmart in 2,200+ stores, food/drug/mass channels), e-commerce (Amazon, Alibaba Tmall Global in China, brand-owned sites), and exclusive healthcare practitioner offices (Life's First Naturals PRO). Its B2B ingredient business generates revenue through exclusive supply agreements with global manufacturers including VitaDairy (Vietnam, renewed through 2026) and Sunplus (China), supporting products such as growing-up milk, bone health formulations, and functional foods. A third stream provides contract manufacturing and toll manufacturing services including spray drying, dry blending, powder fills, sachets, capsules, and chewables.
PanTheryx is privately held and PE-sponsored, with Pegasus Capital Advisors as a consistent investor since 2016 and approximately $190 million raised cumulatively across nine funding rounds through October 2023. The company maintains a scientific advisory board anchored by Dr. Raymond Playford (150+ peer-reviewed publications) and Dr. Michael Roizen (Cleveland Clinic Chief Wellness Officer Emeritus). Leadership includes veterans from DSM, Martek Biosciences, Bayer, and KPMG. The company holds GRAS status for its bovine colostrum, USDA CVB dual-claim licensing for its La Belle animal health line, and CFIA approval for Canada. Its current strategic focus emphasizes the high-growth GLP-1 medication side-effect market (via Relesium, launched November 2024), women's health (TruBiotics Women's, May 2023), and geographic expansion into China and Southeast Asia.
PanTheryx firmographics
Firmographics- Name
- PanTheryx
- Legal name
- PanTheryx, Inc.
- Website
- https://pantheryx.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- PanTheryx is the world's largest producer of bovine colostrum, commercializing proprietary colostrum ingredients and consumer brands (TruBiotics, DiaResQ, Life's First Naturals, Relesium) for digestive, immune, and GLP-1 side-effect support across human and animal health markets globally.
- Ownership category
- akta.pro rank
PanTheryx industry classification
Industry- Product category
- Dietary Supplements (Bovine Colostrum and Probiotics)
- NAICS
- Animal Food Manufacturing (31111)
- SIC
- Food And Kindred Products (2000), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids) (CRADAOAJ)
Keywords
Where PanTheryx is headquartered
LocationHeadquarters
- HQ city
- Boulder
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
PanTheryx business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D, Infrastructure
Revenue model
- Consumer Branded Products: Sale of finished consumer supplement brands including TruBiotics (probiotic), Life's First Naturals (colostrum), DiaResQ (diarrhea support), and Relesium (GLP-1 side effect support) through retail, e-commerce, and healthcare practitioner channels. Revenue from direct product sales to consumers and retail distributors.
- B2B Colostrum Ingredient Supply: Supply of proprietary colostrum ingredients (ColostrumOne, La Belle, ColosIgG 24h) to global partners including VitaDairy (Vietnam), Sunplus (China), and other manufacturers for use in their branded food, beverage, supplement, and nutrition products. Multi-million dollar exclusive supply agreements.
- Contract Manufacturing: In-house contract manufacturing and toll manufacturing services for dietary supplement manufacturers. Capabilities include spray drying, dry blending, powder fills, sachets, capsules, and chewable tablets. Vertically integrated colostrum production from collection through processing.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | TruBiotics Adult Capsules 30-count at Walmart |
| Unit Pricing | Pay-as-you-go | DiaResQ Toddler's at Walmart |
| Unit Pricing | Pay-as-you-go | TruBiotics, Life's First Naturals, DiaResQ on Tmall Global (China) |
Go-to-market motion3 records
Distribution channels7 records
Marketing channels8 records
PanTheryx product offering
Product offeringCore offering
PanTheryx is a vertically integrated nutrition and biotechnology company that manufactures and commercializes bovine colostrum-based ingredients (ColostrumOne, La Belle, ColosIgG 24h, Colostrum Basic Protein) and finished consumer dietary supplements under brands including TruBiotics (probiotics), Relesium (GLP-1 digestive support), DiaResQ (diarrhea support), and Life's First Naturals (colostrum supplements). The company sells proprietary ingredients under exclusive supply agreements to global B2B manufacturers and distributes finished branded products through mass retail (Walmart), e-commerce (Amazon, Alibaba Tmall Global), brand websites, and healthcare practitioner offices.
Product overview
PanTheryx operates as a nutrition and biotechnology company commercializing bovine colostrum-based solutions for human and animal health. The company offers proprietary colostrum ingredients (ColostrumOne and La Belle) to B2B partners while marketing a portfolio of consumer brands including TruBiotics (probiotic supplements), Relesium (GLP-1 side effect support), DiaResQ (diarrhea support), and Life's First Naturals (colostrum supplements). Additional acquired brands include Goodgut and Preliva. Products span multiple delivery formats (capsules, gummies, powders, chewables, drops) targeting digestive health, immune support, and specialized dietary needs across all life stages.
Differentiator
Problem solved
Functional benefit
Brands
- TruBiotics: Daily probiotic supplement brand containing two clinically studied probiotic strains (Bifidobacterium BB-12 and Lactobacillus LA-5) for digestive and immune health. Available for infants, children, and adults in various formats including capsules, gummies, drops, and chewables.
- Relesium
- Life's First Naturals
- DiaResQ
- Goodgut
- Preliva
- ColostrumOne
- La Belle Colostrum
Products and services
- TruBiotics Daily probiotic supplement brand for digestive and immune health across infants, children, and adults, available in capsules, gummies, baby drops, and chewable formats. Sold through Walmart, Amazon, brand websites, and other mass/drug retailers.
- Relesium Patented supplement for adults using GLP-1 medications who experience gastrointestinal side effects. Combines chicken egg powder with PanTheryx bovine colostrum; supported by peer-reviewed Nutrients journal publication.
- DiaResQ Patented Food for Special Dietary Use for diarrhea management in adults and children as young as one year old. Powered by PanTheryx's proprietary ColostrumOne bovine colostrum ingredient.
- Life's First Naturals Bovine colostrum supplement brand for adults and children, available in capsules, flavored chewables, and powders. Powered by PanTheryx's proprietary ColostrumOne ingredient for immune and digestive health.
- ColostrumOne Proprietary bovine colostrum ingredient formulated to protect bioactive components through the digestive system, available in standard and Extra Strength formulations. Sold as a B2B ingredient to global nutrition manufacturers and used internally in PanTheryx's consumer brands.
- La Belle Colostrum Brand of bovine colostrum for animal health providing maternal colostrum replacers and supplements for calves, piglets, lambs, kids, and puppies with USDA and CFIA regulatory clearance.
- Goodgut and Preliva Digestion and immune health consumer brands acquired from Greenteaspoon Inc. in October 2020 and integrated into PanTheryx's human nutrition product portfolio.
- Colostrum Basic Protein (CBP) Small molecule fraction isolated from bovine colostrum through ultra-filtration, containing key growth factors that assist in bone cell proliferation and mineralization. Supplied to B2B partners for inclusion in functional foods and beverages.
- Life's First Naturals PRO Premium bovine colostrum supplement line available exclusively through healthcare practitioner offices (naturopaths, chiropractors, acupuncturists, and integrative medicine practitioners) via pantheryxpro.com. Includes adult and kids ColostrumOne Extra Strength formulas.
- TruBiotics Women Women's-specific probiotic product line under TruBiotics, including capsules for vaginal and bone health and sugar-free gummies with collagen for urinary, hair, skin, and nail health.
- TruBiotics Baby Drops & Kids Chewable Infant and children's probiotic products under TruBiotics, with TruBiotics Baby Drops delivering BB-12 probiotic strain and Kids Chewable tablets for digestive and immune support.
- TruBiotics Sugar-Free Probiotic Gummies Sugar-free gummy probiotic supplements for kids and adults under the TruBiotics brand, featuring Bacillus subtilis DE111 and naturally sweetened with FOS.
- ColosIgG 24h Exclusive PanTheryx bovine colostrum ingredient sourced from the first 24 hours post-calving, trademarked for exclusive supply to VitaDairy in Vietnam for use in ColosBaby growing-up milk and CaloSure America products.
Quantifiable outcome
- ColostrumOne Extra Strength delivers 160% more immune bioactives than other tested colostrum products in an in vivo model of intestinal damage and inflammation (PLOS One study)
- +3 more outcomes
Companies that use PanTheryx
Customer profileNamed customers3 records
Segments6 records
Ideal customer profiles5 records
PanTheryx technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
PanTheryx partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered key, minor and core.
- WalmartkeyPanTheryx expanded TruBiotics Adult Capsules to more than 2,200 Walmart stores nationwide and launched DiaResQ Toddler's in 1,000 Walmart stores as of October 2024. TruBiotics Adult Capsules priced at $14.97 (30-count) and DiaResQ Toddler's at $8.96 (3-pack).
- Jaime Seeman, M.D., OB-GYNminorJaime Seeman, M.D., board-certified Obstetrician and Gynecologist and certified menopause specialist, joined PanTheryx's Scientific Advisory Board in March 2024. She joins existing advisors Michael Roizen, M.D., Lauren Crosby, M.D., Harry Oken, M.D., and Mia Syn, MS, RDN.
- VitaDairycorePanTheryx and VitaDairy (Vietnam's leading dairy company) renewed a three-year exclusive strategic partnership in June 2023. PanTheryx continues as VitaDairy's exclusive producer and supplier of ColosIgG 24h bovine colostrum ingredient. VitaDairy uses this ingredient in ColosBaby growing-up milk for children and mothers and CaloSure America for aging adults. The partnership began in 2019 with a multimillion-dollar agreement and has been renewed through 2026.
- Healthcare Practitioners (Naturopaths, Chiropractors, Acupuncturists)keyLife's First Naturals PRO cow colostrum supplements are distributed exclusively through health care practitioner offices, targeting naturopaths, chiropractors, and acupuncturists who recommend natural digestive and immune health solutions to their patients.
- SunpluscoreAPS (a PanTheryx company) and Sunplus (leading nutrition company in China, founded in Auckland, New Zealand in 1999) announced a multi-year strategic partnership in November 2022 to develop new bovine colostrum products, conduct clinical research, and promote bovine colostrum in China. APS debuted its new Colostrum Basic Protein (CBP) and Immunoglobulin G formula in Sunplus's Natrapure CBPS Milk Powder.
- Alibaba Tmall GlobalkeyPanTheryx opened a Tmall Global flagship store in September 2022 to sell U.S.-made TruBiotics probiotics, Life's First Naturals cow colostrum, and DiaResQ to Chinese consumers seeking science-backed dietary supplements. China's dietary supplements market topped 174.3 billion yuan in 2020.
- Dr. Reddy'skeyPanTheryx and Dr. Reddy's announced an agreement in September 2015 (with exclusive multimillion-dollar agreement announced November 2019) to market PanTheryx's proprietary nutritional intervention for pediatric infectious diarrhea (DiaResQ) in certain markets.
Scale indicators8 records
Recent moves7 records
Expansion highlights7 records
PanTheryx competitors and assessment
Company assessmentBroad incumbents
- Reckitt (Mead Johnson Nutrition): Major infant formula and child nutrition company through its Mead Johnson brand (Enfamil). Competes with PanTheryx's B2B colostrum ingredient supply to infant formula manufacturers and with Life's First Naturals in early life nutrition and digestive health positioning.
- dsm-firmenich: Global nutrition and health giant producing nutritional lipids, vitamins, and human/animal nutrition ingredients. Overlaps with PanTheryx's B2B ingredient supply model; PanTheryx CEO Tom Feeley previously led DSM's global omega-3 business. Competes in early life nutrition, sports nutrition, and animal nutrition adjacencies.
- Novonesis (formerly Chr. Hansen): Global bioscience company producing probiotic cultures, enzymes, and human/animal health ingredients. Competes with PanTheryx in B2B probiotic and culture supply to food, supplement, and dairy manufacturers, and owns the Culturelle consumer brand through its i-Health subsidiary that directly competes with TruBiotics.
- Kerry Group: Global taste and nutrition company supplying functional ingredients and taste solutions to food, beverage, and supplement manufacturers. Overlaps with PanTheryx's B2B ingredient supply model, particularly for synbiotic and digestive health applications in infant nutrition and functional foods.
- ADM (Archer Daniels Midland): Global nutrition and agricultural processor producing human and animal nutrition ingredients, flavors, and functional proteins. Competes with PanTheryx in B2B nutrition ingredient supply and in adjacent animal health/nutrition markets, with significantly larger scale and global distribution.
- Glanbia plc: Global nutrition company with leading positions in dairy-based nutritional ingredients, protein premixes, and consumer health products. Overlaps with PanTheryx's B2B nutrition ingredient supply model, particularly for sports nutrition, infant formula, and whey/protein-based applications.
- Nestlé Health Science: Subsidiary of Nestlé focused on nutritional therapies, medical foods, and consumer health products. Competes with PanTheryx's Life's First Naturals and DiaResQ in digestive health, and operates in pediatric nutrition and GI health categories adjacent to PanTheryx's portfolio.
Emerging players
- Lallemand: Canadian yeast and bacteria producer with growing presence in human and animal probiotics and functional nutrition. Overlaps with PanTheryx in B2B probiotic cultures, synbiotic formulations, and animal nutrition applications, though at smaller scale and less US consumer brand presence.
Direct peers
- BioGaia: Swedish probiotics company selling clinically-documented probiotic strains for digestive and immune health across consumer and pediatric markets. Directly competes with PanTheryx's TruBiotics brand in the probiotic supplement category with similar clinical-evidence positioning and global distribution.
- i-Health (Culturelle): Consumer probiotics brand owned by i-Health (a division of Chr. Hansen/Novonesis) competing directly with TruBiotics in the US mass and drug channels. Both brands target digestive and immune health with clinically-validated probiotic strains and similar shelf placement at Walmart, Amazon, and drug retailers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
PanTheryx social profiles
Digital presencePanTheryx compliance and trust
Trust signalCompliance3 records
PanTheryx financial estimates
Financial estimateRevenue estimate
Valuation estimate
PanTheryx leadership team
Management profileNumber of profiles
Profiles19 records
PanTheryx subsidiaries and ownership
Company hierarchySubsidiaries2 records
PanTheryx funding detail
Funding detailFunding overview
Funding rounds9 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PanTheryx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PanTheryx
What does PanTheryx do?
PanTheryx is a vertically integrated nutrition and biotechnology company that manufactures and commercializes bovine colostrum-based ingredients (ColostrumOne, La Belle, ColosIgG 24h, Colostrum Basic Protein) and finished consumer dietary supplements under brands including TruBiotics (probiotics), Relesium (GLP-1 digestive support), DiaResQ (diarrhea support), and Life's First Naturals (colostrum supplements). The company sells proprietary ingredients under exclusive supply agreements to global B2B manufacturers and distributes finished branded products through mass retail (Walmart), e-commerce (Amazon, Alibaba Tmall Global), brand websites, and healthcare practitioner offices.
Is PanTheryx a public or private company?
PanTheryx is a private company. It is classified as private equity controlled and is currently operating.
When was PanTheryx founded?
PanTheryx was founded in 2007. It employs 101 to 250 people.
Where is PanTheryx based?
PanTheryx is headquartered in Boulder, United States, in the North America region.
How does PanTheryx make money?
Three revenue lines are on record. Consumer Branded Products are the primary driver. The others are B2B Colostrum Ingredient Supply and contract Manufacturing.
Who are PanTheryx's main competitors?
Broad incumbents on record are Reckitt (Mead Johnson Nutrition), dsm-firmenich, Novonesis (formerly Chr. Hansen), Kerry Group, ADM (Archer Daniels Midland), Glanbia plc and Nestlé Health Science. Lallemand is listed as an emerging player. Direct peers are BioGaia and i-Health (Culturelle).
Does PanTheryx have an API?
No public API is recorded for PanTheryx.
What industry is PanTheryx in?
PanTheryx's product category is Dietary Supplements (Bovine Colostrum and Probiotics). Its primary akta.pro industry code is CRADAOAJ, Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids). Its NAICS code is 31111 and its SIC code is 2000.